InvestorsHub Logo
Post# of 353148
Next 10
Followers 0
Posts 1159
Boards Moderated 0
Alias Born 01/12/2006

Re: None

Monday, 04/03/2006 8:41:45 AM

Monday, April 03, 2006 8:41:45 AM

Post# of 353148
Med Gen Inc. MGEN), manufacturers of the national
brands Snorenz(R), snore relief throat spray; Painenz(R), roll on pain
relief formula; Undiet(TM) weight loss system and Good Nights
Sleep(R), sleep aid throat spray, announced today that it has settled
a two year Judgment claim won by former distributors.
The Settlement reduces the amount of the claim from $4 million to
$1.25 million and provides for "payments over time" in an extended
28 month period. The Settlement also provides for a substantial
discount of 10% should the company wish to pre-pay the full amount of
the Settlement or the balance remaining at anytime during the 28 month
payment period. The final portion of the judgment is the issuance of
15 million restricted shares with a registration provision and a
"guarantee put" at the sole discretion of the company valued at
$200,000. In all, the company realized a monetary saving of
approximately $2.75 million.
From a practical standpoint, Mr. Kravitz stated that being free of
the overhang from the judgment and the many financial hurdles that it
posed over the years, allows management to release the company's full
marketing program for its four products. Product commercials and media
advertising plans encompassing e-marketing, mailers and TV
Infomercials will be announced in separate releases.
Those interested in previewing important announcements should
visit the company website on a consistent basis at
http://www.medgen.com as well as our product sites
http://www.snorenz.com, http://www.4goodnightsleep.com and
http://www.painenz.com. A new site for the Undiet(R) system will be
announced in future releases. We also suggest trying our products.

About Med Gen Inc.

Med Gen Inc., in business since 1996, manufactures and markets
the world's first liquid spray snoring relief formula, Snorenz(R) for
which its founders received a patent in 1998. Since its existence,
Med Gen has continued to develop its "sprays the way" technology, and
in 2003 introduced Good Night's Sleep(R) to the sleep-aid market.
Both Snorenz(R) and Good Night's Sleep(R) are nationally advertised
and marketed to major chain and drug stores as well as direct sales
via the company web site.
The company is now completing its testing on a radically different
approach and delivery system for its weight loss program, Undiet(TM).
IRI, a retail data reporting service, suggests that the combined
market for snoring and sleep aides could exceed $500 million and the
weight loss market could exceed $60 billion by 2007.
For further information on Med Gen Inc., please visit
http://www.medgen.com

This Press Release contains or incorporates by reference "forward
looking statements including certain information with respect to plans
and strategies of Med Gen Inc. For this purpose, any statements
contained herein or incorporated herein by references that are not
statements of historical fact may be deemed forward looking
statements. Without limiting the foregoing, the words "believes",
"suggests", "anticipates", "plans", "expects", and similar expressions
are intended to identify forward looking statements. There are a
number of events or actual results of Med Gen operations that could
differ materially from those indicated by such forward looking
statements.

Med Gen, Inc. is a publicly traded company on the OTCBB exchange
"MGEN".



KEYWORD: NORTH AMERICA FLORIDA UNITED STATES
INDUSTRY KEYWORD: SENIORS WOMEN HEALTH MANUFACTURING PROFESSIONAL SERVICES LEGAL RETAIL SUPERMARKET CONSUMER FAMILY MEN
SOURCE: Med Gen Inc.


CONTACT INFORMATION:
Med Gen Inc., Boca Raton
Paul Kravitz, 561-750-1100
http://www.medgen.com


A True Wise Person Realizes How Much They DON’T Know, Rather Than How Much They DO..

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.